Performance evaluation of three DNA sample tracking tools in a whole exome sequencing workflow
Gertjan WilsiD, Céline HelsmoorteliD, Pieter‐Jan VoldersiD, Inge Vereecke, Mauro MilazzoiD, Jo VandesompeleiD, Frauke CoppietersiD, Kim De LeeneeriD, Steve LefeveriD
Abstract
IntroductionNext-generation sequencing applications are becoming indispensable for clinical diagnostics. These experiments require numerous wet and dry lab steps, each one increasing the probability of a sample swap or contamination. Therefore, an identity confirmation at the end of the process is recommended to ensure the right data is used for each patient. MethodsWe tested three commercially available, SNP based sample tracking kits in a diagnostic workflow to evaluate their ease of use and performance. The coverage uniformity, on-target specificity, sample identification and genotyping performance were determined to assess the reliability and the cost-effectiveness of each kit. Results and discussionHands-on time and manual steps are almost identical for the kits from pxlence and Nimagen. The Swift kit has an extra purification step, making it the longest and most demanding protocol. Furthermore, the Swift kit failed to correctly genotype 26 out of the 46 samples. The Nimagen kit identified all but one sample and the pxlence kit unambiguously identified all samples, making it the most reliable and robust kit of this evaluation. The Nimagen kit showed poor on-target mapping rates, resulting in deeper sequencing needs and higher sequencing costs compared to the other two kits. Our conclusion is that the Human Sample ID kit from pxlence is the most cost-effective of the three tested tools for DNA sample tracking and identification. Key pointsO_LIKits from pxlence and Nimagen are easy to use. C_LIO_LIUnambiguous identification of all samples possible with the pxlence kit. C_LIO_LIOnly 20 out of 46 samples were correctly identified with the Swift kit. C_LIO_LIPoor on-target rates for the Nimagen kit results in higher sequencing costs. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.30
- Field percentile
- top 50%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Variant calling pipelines for whole exome sequencing in clinical context
Johanna Stepanian, Diego Saldaña, … Jorge Diaz·medRxiv·Oct 18, 2024
- Genetic Sex Validation for Sample Tracking in Clinical Testing
Hai Hu, Viktoriya Korchina, … Donna Marie Muzny·bioRxiv·Dec 13, 2021
- Performance comparison: exome-sequencing as a single test replacing Sanger-sequencing
Hila Fridman, Concetta A. Bormans, … Doron M. Behar·Molecular Genetics and GenomicsPeer-reviewed·Mar 11, 2021
- Comparative evaluation of four exome enrichment solutions in 2024: Agilent, Roche, Vazyme and Nanodigmbio
Vera Belova, Iuliia A. Vasiliadis, … Dmitriy O. Korostin·BMC GenomicsPeer-reviewed·Jan 27, 2025
- SYSTEM ANALYSIS OF THE SEQUENCING QUALITY OF HUMAN WHOLE EXOME SAMPLES ON BGI NGS PLATFORM
Vera Belova, Anna S. Pavlova, … Dmitriy O. Korostin·Scientific ReportsPeer-reviewed·Jan 12, 2022
- Validation of the NovaSeq6000 Platform and automated library preparation for CE-IVD equivalence
Elena Pasquinelli, Giulia Rollo, … Alessandra Renieri·Computational and Structural Biotechnology JournalPeer-reviewed·Jan 1, 2025